IP Library › Granted Patent US 7,887,503
Granted Patent B2
US 7,887,503 · App. 11/986,299 · Granted Feb 15, 2011

Method and apparatus for removing harmful proteins from a mammalian's ventricular cerebrospinal fluid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,887,503
App. No.
11/986,299
Granted
Feb 15, 2011
Kind
B2
Abstract

A method and apparatus for removing harmful organic anions and proteins from a mammalian's ventricular cerebrospinal fluid in the treatment of brain disorders. One embodiment comprises using an implanted pump and filter system in conjunction with a drug or enzyme to clean and filter a patient's cerebrospinal fluid.

Claims (21)

1. A method for removing harmful organic anions and proteins from a mammalian's ventricular cerebrospinal fluid comprising:

a. implanting a pump and filter system comprising,

i. a power supply compartment

ii. an access port for injecting a medicinal dose and for removing filtered material

iii. drug reservoir and

iv. pump with filter, wherein the access port, the drug reservoir and the pump and filter system are in fluid communication

b. implanting a dual lumen catheter in fluid contact with the pump and filter system and in fluid contact with the spine's sub-arachnoid space

c. supplying a medicinal dose into the drug reservoir via the access port

d. extracting cerebrospinal fluid from the sub-arachnoid space into the drug reservoir via a first lumen of the catheter

e. delivering the cerebrospinal fluid through the filter back into the sub-arachnoid space via a second lumen of the catheter

f. removing filtered material from the pump and filter system via the access port, and

g. supplying another medicinal dose into the drug reservoir via the access port when another medicinal dose is required.

2. The method of claim 1 wherein the medicinal dose is a drug that attracts harmful proteins like A-Beta and Tau.

3. The method of claim 2 wherein the drug is Alzhemed™.

4. The method of claim 1 wherein the medicinal dose is an enzyme capable of digesting A-Beta or other harmful proteins.

5. The method of claim 1 further comprising implanting a diversion catheter in fluid contact with the pump and filter system to divert cerebrospinal fluid to another part of the body and wherein the pump and filter system is externally programmable for at least

h. controlling the rate of filtering cerebrospinal fluid

i. setting a one-time bolus of an amount of cerebrospinal fluid to be diverted to another location of the body to be re-absorbed or

j. setting a slow continuous rate of diverting cerebrospinal fluid to another location of the body to be re-absorbed.

6. The method of claim 5 wherein another part of body is the peritoneal cavity.

7. The method of claim 5 where in another part of the body is the right atrium of the heart.

Continuity (1)
Related Publication 20090131850A1 · May 21, 2009